To hear about similar clinical trials, please enter your email below
Trial Title:
The Importance of Inflammatory Markers Calculated From Preoperative and Postoperative Peripheral Blood Results in the Diagnosis and Treatment of Patients Operated for Hydatid Cyst of the Lung (Lung Echinococcus Granulosus)
NCT ID:
NCT06281522
Condition:
Lung Hydatid Cyst
Conditions: Official terms:
Echinococcosis
Cysts
Parovarian Cyst
Conditions: Keywords:
Lung Hydatid Cyst
neutrophils,
lymphocytes,
platelets
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
Operated patients with hydatid cyst of the lung
Description:
File screening and blood test results will be evaluated
Other name:
File screening and blood test results will be evaluated
Summary:
This study aims to investigate the role of these laboratory findings in the differential
diagnosis and management of pulmonary hydatid cyst (PHC) by examining the number of
euzonophils, neutrophils, lymphocytes, platelets and neutrophil/lymphocyte ratio,
platelet/lymphocyte ratio and systemic immune inflammatory index values in the peripheral
blood of patients diagnosed with pulmonary hydatid cyst (PHC) in the preoperative period
and post-operative 3rd month. Although we have extensive data on hydatid liver cysts,
there is limited information in the literature on the laboratory values of patients with
PHC. This study aims to provide more scientific basis for the diagnosis and management of
PHC and is considered as an inexpensive, reproducible and easily calculable method to
improve the accurate diagnosis and management of AKH in clinical practice.
Detailed description:
Hydatid cyst of the lung (HCC) is a health problem caused by a small species of tapeworm
called Echinococcus granulosus, a parasitic infection that can occur in humans and other
mammals. Hydatid cysts are cysts caused by the larvae of the parasite. They most commonly
form in the liver and lungs, but can also occur in other organs. E. granulosus lives in
the intestines of animals and excretes them in their feces. Humans can get the eggs of
this parasite through contact or under poor hygiene conditions. The ingested eggs hatch
in the stomach and intestine and the larvae enter the bloodstream, then form cysts in
various organs throughout the body.
Cystic echinococcosis is a disease in which a large group of patients live in conditions
of material and social poverty. The disease has a widespread distribution worldwide and
the regions with high disease prevalence are Southeast Europe, the Middle East, North,
Central and East Asia and South America.
Criteria for eligibility:
Study pop:
Peripheral blood results of patients hospitalized in the thoracic surgery clinic of S.B.Ü
Van Training and Research Hospital due to hydatid cyst of the lung (surgery) will be
evaluated.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Between January 1, 2022 - December 1, 2023, patients with hydatid cyst of the lung
who were hospitalized in the Thoracic Surgery Service
Exclusion Criteria:
- Between January 1, 2022 and December 1, 2023, other patients admitted to the
Thoracic Surgery Service
Gender:
All
Minimum age:
18 Years
Maximum age:
83 Years
Locations:
Facility:
Name:
University of Health Sciences, Van Training and Research Hospital
Address:
City:
Van
Country:
Turkey
Status:
Recruiting
Start date:
December 18, 2023
Completion date:
June 30, 2024
Lead sponsor:
Agency:
Abdullah Adiyaman
Agency class:
Other
Source:
Yuzuncu Yıl University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06281522